Ingestible Sensors Market Size & Share 2024 to 2032

Ingestible Sensors Market Size

Ingestible Sensors Market size was valued at USD 849.7 million in 2023 and is expected to reach USD 1.9 billion by 2032 at a CAGR of 9.2% from 2024 to 2032. Growing shift towards preventive healthcare, increase in R&D activities and investments, and supportive regulatory guidelines are among the key factors propelling the market expansion.

Gastrointestinal disorders necessitate ongoing monitoring of physiological parameters like pH levels, temperature, and gastrointestinal pressure to evaluate disease severity, treatment efficacy, and disease progression. Ingestible sensors present non-intrusive and convenient avenues for diagnosing gastrointestinal disorders, furnishing real-time insights into gastric motility, acid reflux, and bowel movement patterns. This enables prompt diagnosis and tailored treatment interventions. The increase in awareness levels, coupled with supportive government policies, plays a pivotal role in advancing early disease diagnosis mechanisms.
 

For example, in September 2022, the American Gastroenterological Association (AGA) launched Trust Your Gut, an awareness campaign, aimed at making people well informed about bowel symptoms to promote early diagnosis of related disorders. Such initiatives will further boost the awareness levels, thereby contributing to industry growth.
 

Ingestible sensors are typically small, electronic devices that can be swallowed or ingested by an individual to collect specific physiological data from within the body and transmit it to an external receiver or device for analysis. They are primarily used in healthcare for various applications such as medical diagnostics, disease monitoring, drug delivery tracking, and personalized health management.
 

Ingestible Sensors Market Trends

Ingestible sensor devices with remote monitoring capabilities allow healthcare providers to remotely monitor patient health status, track treatment progress, and intervene proactively in case of abnormalities or emergencies, improving patient care outcomes.
 

• Integration of advanced data analytics algorithms and artificial intelligence (AI) capabilities within ingestible sensor systems allows for real-time data analysis, interpretation, and actionable insights, facilitating personalized healthcare interventions and treatment optimization.
   
• Additionally, continuous advancements in microelectronics and nanotechnology have enabled the miniaturization of ingestible sensor devices, allowing them to be more discreet, comfortable to swallow, and less intrusive within the body.
   
• Further adoption of wireless communication technologies such as Bluetooth Low Energy (BLE) and Near Field Communication (NFC) enables ingestible sensors to wirelessly transmit data to external devices such as smartphones, tablets, or wearable devices in real-time.
   

Ingestible Sensors Market Analysis

The market by component is categorized into sensors, wearable patch/data recorder, and software. The sensors segment dominates the market with a revenue of USD 459.4 million in 2023.
 

• Sensors that can accurately measure parameters such as temperature, pH levels, pressure, and biomarkers within the gastrointestinal tract are essential for diagnosing conditions like gastrointestinal disorders, acid reflux, and digestive issues. The increasing prevalence of chronic diseases and the growing demand for personalized healthcare solutions drive the demand for ingestible sensors for medical diagnostics and continuous monitoring.
   
• Ingestible sensors play a crucial role in drug delivery monitoring by tracking medication adherence, dosage timing, and drug absorption rates within the body. Sensors that can monitor drug release kinetics, detect changes in physiological responses and provide real-time feedback to healthcare providers that can drive growth in this segment, particularly in pharmaceutical research and clinical trials.

The ingestible sensors market by application is categorized into medical and sports and fitness. The medical segment accounted for majority revenue share and was valued at USD 631.7 million in 2023.
 

• Ingestible sensors are used for different purposes in the medical domain including remote patient monitoring, disease diagnostic, treatment optimization, and personalized medicine, among others. For example, these sensors support the ongoing shift towards personalized medicine by providing real-time data on individual patient responses to treatment. Sensors that can collect and analyze physiological data, identify biomarkers, and predict disease risk enable personalized treatment approaches tailored to each patient's unique needs, preferences, and genetic makeup.
   
• Additionally, ingestible sensors are notably used by pharmaceutical companies in clinical research and trials to collect objective data on drug efficacy, patient response to treatment, and disease progression. Sensors that can monitor patient outcomes, adherence to study protocols, and adverse events facilitate data-driven decision-making, accelerate drug development, and improve clinical trials efficiency.

Learn more about the key segments shaping this market

Download Free PDF

The ingestible sensors market by end-use is categorized into hospitals and clinics, sports and fitness centers, pharmaceutical companies, and other end-users. The hospitals and clinics segment exceeded USD 408.7 million in 2023.
 

• Ingestible sensors are used to monitor medication adherence and track drug absorption rates in patients with chronic medical conditions such as inflammatory bowel disease (IBD), diabetes, and cardiovascular disease. Sensors embedded in oral medications transmit real-time data on medication ingestion, dosage timing, and drug release kinetics, enabling healthcare providers in hospitals and clinics to optimize treatment regimens and improve therapeutic outcomes.
   
• Moreover, ingestible camera capsules, also known as capsule endoscopy, are used for non-invasive imaging of the gastrointestinal tract. These capsules contain miniature cameras that capture high-resolution images as they pass through the digestive system, allowing healthcare providers to visualize the esophagus, stomach, small intestine, and colon for the detection of abnormalities such as ulcers, polyps, and tumors.

North America ingestible sensors market accounted for USD 355.6 million revenue in 2023 and is predicted to witness substantial market growth.
 

• There is a growing awareness among consumers in North America about the benefits of digital health technologies, including ingestible sensors, for personalized healthcare and wellness management. Increased consumer adoption of wearable devices, smartphone apps, and telemedicine platforms that integrate ingestible sensor data further drives demand for these sensors in the region.
   
• Additionally, there is a significant demand and growing trend of fitness and sports related activities and developments in the region. These sensors are increasingly being used in sports and fitness applications for monitoring hydration levels, electrolyte balance, and performance metrics during physical activity.
   
• Sensors that can provide actionable insights into an individual's physiological responses to exercise, optimize training regimens, and prevent dehydration or overexertion can drive demand in this segment, particularly among athletes, sports teams, and fitness enthusiasts.
   

Ingestible Sensors Market Share

Key players focus on expanding their market presence and geographic reach through strategic investments, acquisitions, and partnerships. This includes entering new geographic markets, establishing distribution networks, and strengthening their presence in key regions with high demand for ingestible sensor technologies.
 

Ingestible Sensors Market Companies

Some of the eminent market participants operating in the ingestible sensors industry include:

• BodyCAP
• CapsoVision, Inc.
• Check-Cap
• etectRx
• IntroMedic
• JINSHAN Science & Technology
• Koninklijke Philips N.V.
• Medtronic plc
• Olympus Corporation
• Otsuka Holdings Co., Ltd.
   

Ingestible Sensors Industry News:

• In October 2023, BodyCAP, a French medical technology company, received U.S. FDA approval for its ‘eCelsius Medical System’ a connected ingestible thermometer, in the U.S. This development may help the company in expanding its product portfolio and improve its customer reach in the country.
   

Ingestible sensors market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Component

• Sensors
  • Temperature sensor
  • Pressure sensor
  • pH sensor
  • Image sensor 
• Wearable patch/Data recorder
• Software

Market, By Application

• Medical
• Sports and fitness

Market, By End-use

• Hospitals and clinics
• Sports and fitness centers
• Pharmaceutical companies
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa